The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs against diseases of the central nervous system (CNS). Because of this barrier there is still a huge unmet need for the treatment of these diseases. despite years of research efforts across the pharmaceutical industry. Novel therapeutic entities. https://www.maximilianopellegrini.com/product-category/dagcreme-med-spf/